Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Medical Stocks' Q1 Earnings Releases on May 10: ICUI, ZLTQ

This week – with 559 companies set to report their results – will witness the last rush of the first-quarter earnings release. While there is a remote chance for the prime line sectors, entangled in several global economic woes, to come out of the doldrums observed through the quarter under review, we expect Medical to break this plateau with solid Q1 earnings growth.

As per our latest Earnings Trends report, so far, more than 92% of the Medical sector index members have released their first-quarter financial numbers, out of which 79.6% have reported better-than-expected earnings performance on revenue beat of 69.4%. Accordingly, earnings were up 8.1% year over year on a 10% revenue growth rate.

The following are two of the popular names in the medical space, gearing up to report results on May 10. Let’s see how these stocks are poised ahead of the scheduled announcements.

ICU Medical, Inc., ICUI is a global medical technology company that focuses on infusion therapy, oncology and critical care applications. The company works on prevention of bloodstream infections and protection from exposure to infectious diseases or hazardous drugs.

This Zacks Rank #3 (Hold) stock’s track record has been impressive with the company beating earnings estimates in three of the last four quarters. However, an Earnings ESP of 0.00%, combined with a Zacks Rank #3, does not conclusively show that the company is likely to beat earnings estimates this quarter.

Another medical technology company slated to report earnings is ZELTIQ Aesthetics, Inc. ZLTQ. This company is a provider of non-invasive products for the selective reduction of fat. ZELTIQ's first commercial product, the CoolSculpting system, is designed to selectively reduce unwanted fat that may not respond to diet or exercise.

ZELTIQ has an impressive track record, having beaten estimates comfortably in three of the last four quarters. However, the combination of the company’s Zacks Rank #3 and 0.00% ESP makes surprise prediction difficult.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ICU MEDICAL INC (ICUI): Free Stock Analysis Report
 
ZELTIQ AESTHETC (ZLTQ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research